Frequency, risk factors and prognosis of postoperative hyperbilirubinemia after heart valve surgery

Cardiology (Switzerland)

Volumn 122, Issue 1, 2012, Pages 12-19

  Nishi, Hiroyuki ^a   Sakaguchi, Taichi ^a   Miyagawa, Shigeru ^a   Yoshikawa, Yasushi ^a   Fukushima, Satsuki ^a   Saito, Shunsuke ^a   Ueno, Takayoshi ^a   Kuratani, Toru ^a   Sawa, Yoshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Heart valve surgery; Hyperbilirubinemia; Liver dysfunction

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL ENDOCARDITIS; BILIRUBIN BLOOD LEVEL; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; FREQUENCY ANALYSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VALVE SURGERY; HUMAN; HYPERBILIRUBINEMIA; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TRANSFUSION;

AGED; CARDIAC SURGICAL PROCEDURES; ENDOCARDITIS; FEMALE; HEART FAILURE; HEART VALVE DISEASES; HOSPITAL MORTALITY; HUMANS; HYPERBILIRUBINEMIA; LENGTH OF STAY; LIVER DISEASES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC;

EID: 84861639311     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000338142     Document Type: Article

References (27)

1. Lockey E, Mclntyre N, Ross DN, Brookes E, Sturridge MF: Early jaundice after openheart surgery. Thorax 1967; 22: 165-169.
2. Sanderson RG, Ellison JH, Benson JA, Starr A: Jaundice following open heart surgery. Ann Surg 1967; 165: 217-224.
3. Collins JD, Bassendine MF, Ferner R, Blesovsky A, Murray A, Pearson DT, James OF: Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet 1983; 1: 1119-1123. (Pubitemid 13084670)
4. Olsson R, Hermodsson S, Roberts D, Waldenstrom J: Hepatic dysfunction after open-heart surgery. Scand J Thorc Cardiovasc Surg 1984; 18: 217-222. (Pubitemid 15191190)
5. Chu CM, Chang CH, Liaw YF, Hsieh MJ: Jaundice after open-heart surgey: a prospective study. Thorax 1984; 39: 52-56.
6. Wang MJ, Chao A, Huang CH, CH, Lin FY, Wang SS, Liu CC, Chu SH: Hyperbilirubinemia after cardiac operation. Incidence, risk factors, and clinical significance. J Thorac Cardvasc Surg 1994; 108: 429-436. (Pubitemid 24299667)
7. Michalopoulos A, Alivizatos P, Geroulanos S: Hepatic dysfunction following cardiac surgery: determinants and consequences. Hepatogastroenterology 1997; 44: 779-783. (Pubitemid 27281117)
8. Hosotsubo KK, Nishimura M, Nishimura S: Hyperbilirubinemia after major thoracic surgery: comparison between open-heart surgery and oesophagectomy. Crit Care 2000; 4: 180-187. (Pubitemid 30368050)
9. An Y, Xiao YB, Zhong QJ: Hyperbilirubinemia after extracorponeal circulation surgery: a recent and prospective study. World J Gastroenterol 2006; 12: 6722-6726. (Pubitemid 44794956)
10. Mastoraki A, Karatzis E, Mastoraki S, Kriaras I, Sfirakis P, Geroulanos S: Postoperative jaundice after cardiac surgery. Hepatobiliary Pancreat Dis Int 2007; 6: 383-387. (Pubitemid 47288121)
11. Robinson JS, Cole FR, Gibson P Simpson JA: Jaundice following cardiopulmonary bypass. Thorax 1967; 22: 232-237.
12. Motomura N, Miyata H, Tsukihara H, Takamoto S, Japan Cardiovascular Surgery Database Organization: Risk model of thoracic aortic surgery in 4,707 cases from a nationwide single-race population through a webbased data entry system: the first report of 30-day and 30-day operative outcome risk models for thoracic aortic surgery. Circulation 2008; 118(14 suppl):S153-S159.
13. Nishi H, Takahashi T, Ichikawa H, Matsumiya G, Matsuda S, Sawa Y: Prediction of postoperative hepatic dysfunction after cardiac surgery in patients with chronic congestive heart failure. Gen Thorac Cardiovasc Surg 2009; 57: 357-362.
14. Hsu RB, Lin FY, Chen RJ, Chou NK, Ko WJ, Chi NH, Wang SS, Chu SH: Incidence, risk factors, and prognosis of postoperative hyperbilirubinemia after heart transplantation. Eur J Cardiothorac Surg 2007; 32: 917-922. (Pubitemid 350052579)
15. Desai JB, Ohri SK: Gastrointestinal damage following cardiopulmonary bypass. Perfusion 1990; 5: 161-168. (Pubitemid 20270706)
16. D'Ancona G, Baillot R, Poirier B, Dagenais F, de Ibarra JI, Bauset R, Mathieu P, Doyle D: Determinants of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 2003; 30: 280-305.
17. Paparella D, Yau TM, Young E: Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21: 232-244. (Pubitemid 34135370)
18. Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D: Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 2000; 140: 111-120. (Pubitemid 30471249)
19. Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, CHARM Investigators: Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 2009; 11: 170-177.
20. Lau GT, Tan HC, Kritharides L: Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002; 90: 1405-1409. (Pubitemid 35449493)
21. Goldberg DM, Martin JV: Role of gammaglutamyl transpeptidase activity in the diagnosis of hepatobiliary disease. Digestion 1975; 12: 232-246.
22. Giannini EG, Testa R, Savarino V: Liver enzyme alteration: a guide for clinicians. CMAJ 2005; 172: 367-379. (Pubitemid 40208726)
23. Hirata N, Sawa Y, Matsuda H: Predictive value of preoperative serum cholinesterase concentration in patients with liver dysfunction undergoing cardiac surgery. J Card Surg 1999; 14: 172-177. (Pubitemid 30230654)
24. Batin M, Wickens M, Mcentegart D, Fullwood L, Cowley AJ: The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 1995; 16: 1613-1618. (Pubitemid 26037793)
25. Kubo SH, Walter BA, John DHA, Clark M, Cody RJ: Liver function abnormalities in chronic heart failure. Arch Intern Med 1987; 147: 1227-1230.
26. Takano H, Matsuda H, Kadoba K, Kawata H, Sawa Y, Shimazaki Y, Taenaka N: Monitoring of hepatic venous oxygen saturation for predicting acute liver dysfunction after Fontan operations. J Thorac Cardiovasc Surg 1994; 108: 700-708. (Pubitemid 24330248)
27. Matsuda H, Takano H, Nakano H, Shirakura R, Ohtani M, Taniguchi K, Miyamoto Y, Ohtake S, Sawa Y, Taenaka N: Analysis of acute and chronic heart failure in view of hepatic oxygen supply-demand relationship using hepatic venous oxygen saturation. Jpn Circ J 1989; 53: 175-179. (Pubitemid 19133819)